Wordt geladen...
Increased MIR31HG lncRNA expression increases gefitinib resistance in non-small cell lung cancer cell lines through the EGFR/PI3K/AKT signaling pathway
The aim of the present study was to gain insight into the molecular mechanism of gefitinib resistance in non-small cell lung cancer (NSCLC), and demonstrate whether long noncoding RNA (lncRNA) expression signatures differ between gefitinib-sensitive PC9 and gefitinib-resistant PC9 (PC9-R) cell lines...
Bewaard in:
| Gepubliceerd in: | Oncol Lett |
|---|---|
| Hoofdauteurs: | , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
D.A. Spandidos
2017
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5431660/ https://ncbi.nlm.nih.gov/pubmed/28529576 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2017.5878 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|